ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,20%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,1288
-0,03%
Bitcoin
66.269,63
1,59%
Brent Oil
83,155
-0,06%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aerovate Therapeutics Inc (AVTE)

  7. Aerovate Therapeutics Inc (AVTE) Notícias

AVTE

Aerovate Therapeutics (AVTE)

Aerovate Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVTE
DataHoraFonteTítuloCódigoCompanhia
13/05/202417:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTEAerovate Therapeutics Inc
13/05/202417:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTEAerovate Therapeutics Inc
13/05/202417:30GlobeNewswire Inc.Aerovate Therapeutics Announces First Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
27/03/202410:20GlobeNewswire Inc.Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
25/03/202417:10GlobeNewswire Inc.Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
11/03/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
07/03/202418:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVTEAerovate Therapeutics Inc
06/03/202410:00GlobeNewswire Inc.Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board ChairNASDAQ:AVTEAerovate Therapeutics Inc
09/02/202418:28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVTEAerovate Therapeutics Inc
08/01/202419:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVTEAerovate Therapeutics Inc
20/11/202318:45GlobeNewswire Inc.Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial HypertensionNASDAQ:AVTEAerovate Therapeutics Inc
13/11/202310:00GlobeNewswire Inc.Aerovate Therapeutics Announces Third Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
14/08/202309:00GlobeNewswire Inc.Aerovate Therapeutics Announces Second Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
11/07/202318:00GlobeNewswire Inc.Aerovate Therapeutics Appoints Habib Dable To Its Board of DirectorsNASDAQ:AVTEAerovate Therapeutics Inc
27/06/202318:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVTEAerovate Therapeutics Inc
08/06/202319:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVTEAerovate Therapeutics Inc
08/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVTEAerovate Therapeutics Inc
06/06/202317:23Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVTEAerovate Therapeutics Inc
01/06/202309:00GlobeNewswire Inc.Aerovate Therapeutics to Present at Jefferies Global Healthcare ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
22/05/202314:15GlobeNewswire Inc.Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
15/05/202317:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVTEAerovate Therapeutics Inc
15/05/202317:05GlobeNewswire Inc.Aerovate Therapeutics Announces First Quarter Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
19/04/202317:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVTEAerovate Therapeutics Inc
19/04/202317:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVTEAerovate Therapeutics Inc
05/04/202317:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AVTEAerovate Therapeutics Inc
29/03/202318:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AVTEAerovate Therapeutics Inc
29/03/202318:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVTEAerovate Therapeutics Inc
29/03/202317:50GlobeNewswire Inc.Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business HighlightsNASDAQ:AVTEAerovate Therapeutics Inc
08/03/202320:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AVTEAerovate Therapeutics Inc
02/03/202310:00GlobeNewswire Inc.Aerovate Therapeutics to Present at Cowen 43rd Annual Health Care ConferenceNASDAQ:AVTEAerovate Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVTE

Seu Histórico Recente

EU
WFIN
Spdr Msci World Financia...
USOTC
LNNNY
Leoni (CE)
AMEX
RZV
Invesco S&P SmallCap 600...
LSE
34MO
Sg Issuer 26
COIN
MNEXUSD
BIT
S28168
Societe Generale Effekten
BOV
LAND3R
Terra Santa Propriedades... ON
LSE
EUCF
Ishr E C Fin
BIT
SNFXL5
Societe Generale Effekten
ASX
AWKN
ASE
LAVI
Lavipharm
LBNK
PTXUSDT
PandoProject
COIN
LEOUSD
Bitfinex LEO Token
LSE
67JH
Finnvera 25
EU
TRACT
Teract
BIT
SBDU5S
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados